Ignite Creation Date:
2024-05-06 @ 7:31 PM
Last Modification Date:
2024-10-26 @ 3:09 PM
Study NCT ID:
NCT06048315
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-09-21
First Post:
2023-09-10
Brief Title:
A Single Center Single Arm Clinical Study on the Treatment of Advanced Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations and Failed EGFR TKIs With the Combination of Enrotinib and Paclitaxel Monoclonal Antibody
Sponsor:
Degan Lu
Organization:
Qianfoshan Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lung Cancer |
| TKI Resistance |
| EGFR Sensitive Mutation |
| Anlotinib |
| Pianzumab |
Keywords: